Pathogenesis and management issues for non-alcoholic fatty liver disease - Wikidata - awgldk - TriplyDB

Pathogenesis and management issues for non-alcoholic fatty liver disease

Pathogenesis and management issues for non-alcoholic fatty liver disease

http://www.wikidata.org/entity/Q36179902

about

Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective Signal transductions and nonalcoholic fatty liver: a mini-review Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update Oxidative stress in obesity: a critical component in human diseases Histological course of nonalcoholic fatty liver disease in Japanese patients: tight glycemic control, rather than weight reduction, ameliorates liver fibrosis.Fatty liver disease in children: eat now pay later.Inflammatory mediators of hepatic steatosis.Nutrition and exercise in the management of liver cirrhosis Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series The medical risks of obesity.Development of diet-induced fatty liver disease in the aging mouse is suppressed by brief daily exposure to low-magnitude mechanical signals.Saturated fatty acid induction of endoplasmic reticulum stress and apoptosis in human liver cells via the PERK/ATF4/CHOP signaling pathway.Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India.TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats.Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis Inflammation, oxidative stress, and obesity.6-gingerol protects against nutritional steatohepatitis by regulating key genes related to inflammation and lipid metabolism.Reduction of oxidative stress attenuates lipoapoptosis exacerbated by hypoxia in human hepatocytes.Evaluation of atherosclerotic findings in patients with nonalcoholic fatty liver disease.Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis.Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?Evaluation of relationship between grading of fatty liver and severity of atherosclerotic finding.Water Soluble Vitamin E Administration in Wistar Rats with Non-alcoholic Fatty Liver Disease.Raised liver enzymes in newly diagnosed Type 2 diabetes are associated with weight and lipids, but not glycaemic control.The prevalence of metabolic risk factors among outpatients with diagnosed nonalcoholic fatty liver disease in Lithuania.Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis Probiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidences Liver dysfunction in Turner's syndrome: prevalence, natural history and effect of exogenous oestrogen.Non alcoholic fatty liver disease and metabolic syndrome.Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms.Signal transduction mechanism of TRB3 in rats with non-alcoholic fatty liver disease Hypertension and hepatic steatosis.Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option?Inflammation and liver.Recent advances in the herbal treatment of non-alcoholic Fatty liver disease.Ezetimibe reduces cholesterol content and NF-kappaB activation in liver but not in intestinal tissue in guinea pigs.Probiotics and Nonalcoholic Fatty liver Disease.Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment.Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease.

P2860

Q26863476-BFAD161E-A1DA-417A-B523-AE6DEA2A0AD6 Q26991757-3E93645C-CE9A-4216-9CC5-43954339E7DA Q26997059-5A83D1B6-BE9C-40FC-983A-AC517EBDE353 Q28082703-00B0BE63-AAC9-4FA2-9DFA-2CCCE3F24418 Q33602167-65F70862-8C14-4F94-9711-036DF9CA9124 Q33718945-518954D9-4E0B-4CFC-809A-7BDD4DE66141 Q33734136-CB4533C3-7B3A-41BE-9329-3614304AE598 Q33780141-352310B8-0D29-4B33-ACA9-DE301D367034 Q33816223-AFB58E41-F38F-459F-850A-BDCEDEB3DE24 Q33888248-3F62B979-D040-4686-8FA6-7AF6D76D4084 Q34087887-8DA96345-FEFD-46F5-8889-3DB059374BC0 Q34128069-BA9ED733-84F1-4841-B0B0-D5DE318D2AC7 Q34550839-C815B1FC-6E63-4640-8E47-DA436B3CC3D5 Q34721238-A8BDBD34-2D97-4A30-A996-496C80C495F4 Q35009517-6A768A07-5B9A-4D87-A044-0985B0BEFA2B Q35048584-788D98EC-5706-47F3-8EE9-9E488DFC96D8 Q35131341-0B362076-B92A-4A96-A41D-2BFD200FC8AE Q35139035-BA8B70A3-83D8-48DB-9917-9C92B37FDFA6 Q35560585-979B6EBD-01C4-44C5-BB12-E6C17777055A Q35716357-074DEC53-6894-40F3-95E5-A8C83D981E7D Q36105525-C05EDE4F-430A-42A3-AC2F-05D2A7B5E946 Q36111640-BB473F8E-4D08-4C8D-8AE8-2E843F079369 Q36192489-8F368DDC-AB87-417E-9BC1-8401D0420F16 Q36436401-8A066401-9111-49BC-A5EF-08AA1AD23B20 Q36577007-6B574F72-8FC6-46A6-BD5C-4265D6257802 Q36872035-1A51931C-0FAE-4720-8845-DE3BE625139A Q37025294-DFA7FA1C-1040-44DD-BFD6-065E35C37DFF Q37034650-B58C846A-F276-4802-BB77-A1D0BEBDB668 Q37076529-1B3AFEF0-285C-4251-8C15-4A5986DFE6E5 Q37078311-8488805A-AC39-4351-BF36-85806D538E95 Q37192623-C5CA8BA7-7792-4161-9092-4857FA2C3085 Q37198294-4DEAFB2B-A0D5-40BE-ACA5-DF8B917A1FA7 Q37258815-9D96B058-1ABD-4766-846B-8E78E392E887 Q37313049-DD77756F-F4BF-4529-9A5B-5C4F0B6D4787 Q37313768-412743B1-BCCB-4F4D-AF60-20F2EF474422 Q37585296-246D258C-1790-46EB-BAEA-2410520DB6D0 Q37620806-EF4BCA5A-19C4-49E5-9C2E-2FF5FAF809D5 Q37708418-6B219212-6148-4311-ADDC-C8EE6D829C4A Q37847587-3B929347-0542-4FD4-B618-4B0C4A6B7F2A Q37858449-11DDB19A-2327-4E46-9DA1-28C03230FD21

P2860

Pathogenesis and management issues for non-alcoholic fatty liver disease

http://www.wikidata.org/entity/Q36179902

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Pathogenesis and management issues for non-alcoholic fatty liver disease

@ast

Pathogenesis and management issues for non-alcoholic fatty liver disease

@en

type

label

Pathogenesis and management issues for non-alcoholic fatty liver disease

@ast

Pathogenesis and management issues for non-alcoholic fatty liver disease

@en

prefLabel

Pathogenesis and management issues for non-alcoholic fatty liver disease

@ast

Pathogenesis and management issues for non-alcoholic fatty liver disease

@en

P1433

Q36179902-BDB537E0-0D38-48A6-B5E3-E974B3CF8816

P1476

Q36179902-6E1F88AC-0218-4601-B272-6BA37B76B669

P2093

Q36179902-38004C68-BCC5-42A2-AB48-ACA17247E1EC

Q36179902-48461523-19A9-4CC6-8673-DA9BF9C74339

Q36179902-646ECD30-6454-4A77-A5EE-332B9B22ABEB

Q36179902-67F34EF1-2F6E-4F12-A8EA-4FA588632BAC

Q36179902-BAD088E4-06DA-4B6D-9959-9F95B412C823

Q36179902-FE6DD879-1EAF-4063-8118-B0F12BBC3006

P2860

Q36179902-00480FF0-079A-4A10-B32A-E1B39AA7D9CC

Q36179902-00A61227-AFB3-4606-A9B5-BFF3A9DBA898

Q36179902-012FFDA3-A38D-4B2A-82EB-C051215A3FC8

Q36179902-020EB1E6-013C-4853-BD28-1CF7CC239ED9

Q36179902-025C64C3-6444-4E9C-8E7C-23925915CB7A

Q36179902-04147DA2-0C05-4D7A-B6C3-59571FB72AB5

Q36179902-09D56925-A250-4ACA-B38F-FA64704C26C8

Q36179902-09F121B4-1DA2-45FB-8CC4-723DA4133945

Q36179902-0CC28429-EEBC-434C-9E7A-B47A427D646B

Q36179902-0D209458-DC2F-45A2-8A4C-884CA40AAB78

P304

Q36179902-1A36E657-A3B3-49E5-B15A-14739005DD4C

P31

Q36179902-88238A2A-B1FC-41A5-923B-6952D668646D

Q36179902-f891d779-e359-48c0-8fcd-a50d951fa32a

P356

Q36179902-3AA1EA9B-CE22-4EFD-A36F-B224F89ADAF0

P407

Q36179902-BF24AECB-815B-46C7-9B63-59FF27FF9905

P433

Q36179902-483DC5FE-7D09-4DC3-AA0F-E1F6174A175A

P478

Q36179902-A725D504-01E8-45D6-B3CD-DB176AE1C3B1

P577

Q36179902-C32E6578-886C-47E7-B3C6-5E3A92143E38

P5875

Q36179902-F43A7ABB-76B5-4DA7-BA72-8BBAFF05B179

P698

Q36179902-81F19DAC-B0EB-45D8-88C3-6C0D3AF05F18

P921

Q36179902-7A4887C1-60F7-445A-B6F0-61D9BA45826F

P932

Q36179902-0F8363CD-9254-4F37-8B83-92836819E987

P356

WJG.V13.I34.4539

P1433

World Journal of Gastroenterology

P1476

Pathogenesis and management issues for non-alcoholic fatty liver disease

@en

P2093

Ivan Lerotić

http://www.w3.org/2001/XMLSchema#string

Lucija Virović Jukić

http://www.w3.org/2001/XMLSchema#string

Marko Duvnjak

http://www.w3.org/2001/XMLSchema#string

Neven Barsić

http://www.w3.org/2001/XMLSchema#string

Vedran Tomasić

http://www.w3.org/2001/XMLSchema#string

Vedran Velagić

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

Obesity is associated with macrophage accumulation in adipose tissue

Liver fibrosis in overweight patients

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

Sterol regulatory element-binding protein (SREBP)-1: gene regulatory target for insulin resistance?

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

Idiopathic steatohepatitis in childhood: a multicenter retrospective study

P304

4539-4550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V13.I34.4539

http://www.w3.org/2001/XMLSchema#string

P407

P433

34

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6111841

http://www.w3.org/2001/XMLSchema#string

P698

17729403

http://www.w3.org/2001/XMLSchema#string

P921

P932

4611824

http://www.w3.org/2001/XMLSchema#string